Gene-editing therapies not yet ready for human trials, Stanford expert says
- Source
- South China Morning Post - Business
- Source link
- https://www.scmp.com/business/article/3364061/gene-editing-therapies-not-yet-ready-human-trials-stanford-expert-says
- Published
- 2026-08-14 10:00:12
- Discovered by ProcIntel
- 2026-08-14 12:11:35
- Category
- Procurement & Supply Chain News
- Geography
- China
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Gene-editing therapies for the nervous system may need at least another round of studies before they are safe enough to enter human trials, according to one of the world’s most influential figures in the commercialisation of brain science. “The techniques are reasonably well established for animal experiments, but they really haven’t been as mature for human studies,” said Karoly Nikolich, an adjunct professor at Stanford University School of Medicine, in an exclusive interview with the South...
Procurement Relevance Gate
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.